These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36959411)

  • 21. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
    Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
    AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
    Lee VH; Yamahara H; Gurny R; Sintzel MB; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder SK
    J Ocul Pharmacol Ther; 1996; 12(2):103-13. PubMed ID: 8773926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.
    Le Merdy M; AlQaraghuli F; Tan ML; Walenga R; Babiskin A; Zhao L; Lukacova V
    Pharm Res; 2023 Feb; 40(2):431-447. PubMed ID: 36151444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular timolol levels after drug withdrawal: an experimental model.
    Trope GE; Menon IA; Liu GS; Thibodeau JR; Becker MA; Persad SD
    Can J Ophthalmol; 1994 Oct; 29(5):217-9. PubMed ID: 7859172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.
    Suzuki G; Kunikane E; Shinno K; Kozai S; Kurata M; Kawamura A
    Ophthalmol Ther; 2020 Mar; 9(1):115-125. PubMed ID: 31953739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition.
    Podder SK; Moy KC; Lee VH
    Exp Eye Res; 1992 May; 54(5):747-57. PubMed ID: 1623960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of aqueous humor concentrations of Istalol and Betimol following a single ocular instillation in rabbit eyes.
    Baklayan GA; Collins EC; Thetford T; Soriano A; Song CK; Han J
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):507-12. PubMed ID: 18800867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of the ocular bioavailability of timolol by sorbic acid.
    Higashiyama M; Inada K; Ohtori A; Tojo K
    Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
    Aggarwal D; Kaur IP
    Int J Pharm; 2005 Feb; 290(1-2):155-9. PubMed ID: 15664141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to blood flow in the rabbit ophthalmic artery after topical treatment with timolol.
    Liu JH; Li R; Nelson TR; Weinreb RN
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):103-9. PubMed ID: 17444797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of trabeculectomy with topically applied timolol in a rabbit ocular hypertension model.
    Lu DW; Chiang CH; Shang ST; Chou PI
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):323-9. PubMed ID: 9715435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.
    Yuan J; Zhai JJ; Chen JQ; Ye CT; Zhou SY
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):345-50. PubMed ID: 19492954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
    Mori A; Yabuta C; Kishimoto Y; Kozai S; Ohtori A; Shearer TR; Azuma M
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):556-566. PubMed ID: 28598703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
    Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
    J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.